Study to examine the efficacy of modified treat and extend regimen of aflibercept to branch retinal vein occlusion with cystoid macular edema

Not Applicable

Completed

• Conditions: branch retinal vein occlusion

• Registration Number: JPRN-UMIN000024587
• Lead Sponsor: Jichi Medical University

Brief Summary

Arai Y, Takahashi H, Inoda S, Sakamoto S, Tan X, Inoue Y, Tominaga S, Kawashima H, Yanagi Y. Efficacy of Modified Treat-and-Extend Aflibercept Regimen for Macular Edema Due to Branch Retinal Vein Occlusion: 1-Year Prospective Study. J Clin Med 2020 Arai Y, Takahashi H, Inoda S, Sakamoto S, Tan X, Inoue Y, Tominaga S, Kawashima H, Yanagi Y. Efficacy of Modified Treat-and-Extend Regimen of Aflibercept for Macular Edema from Branch Retinal Vein Occlusion:2-Year Prospective Study Outcomes. J Clin Med 2021

Detailed Description

Not available

Study Timeline

• Study Start: 2016-10-27
• Study Completion: 2020-09-30
• Last Update Posted: 17 October 2023

Recruitment & Eligibility

• Status: Complete: follow-up complete
• Sex: All
• Target Recruitment: 50

Inclusion Criteria

Not provided

Exclusion Criteria

Target eye: Prior treatment with anti-VEGF drug and steroid drug Prior treatment with intraocular surgery (<3 months) Another diseases to decrease visual acuity Prior treatment with vitrectomy Fellow eye is already enrolled in the study (If already both eyes onset, the eye which has wider occlusion area is enrolled.) Prior history of brain cardiovascular evebts Patient who the doctor in charge judges are ineligible for the study

Study & Design

• Study Type: Interventional
• Study Design: Not specified